1. |
Shields JA, Shields CL, Honavar SG, et al. Clinical variations and complications of Coats disease in 150 cases: the 2000 Stanford Gifford Memorial Lecture[J]. Am J Ophthalmol, 2001, 131(5): 561-571. DOI: 10.1016/s0002-9394(00)00883-7.
|
2. |
Bonnet M. Coats' syndrome[J]. J Fr Ophtalmol, 1980, 3(1): 57-66.
|
3. |
Morris B, Foot B, Mulvihill A. A population-based study of Coats disease in the United Kingdom Ⅰ: epidemiology and clinical features at diagnosis[J]. Eye (Lond), 2010, 24(12): 1797-1801. DOI: 10.1038/eye.2010.126.
|
4. |
Jonas JB, Holbach LM. Clinical-pathologic correlation in Coats' disease[J]. Graefe's Arch Clin Exp Ophthalmol, 2001, 239(7): 544-545. DOI: 10.1007/s004170100299.
|
5. |
Spitznas M, Joussen F, Wessing A, et al. Coat's disease. An epidemiologic and fluorescein angiographic study[J]. Albrecht Von Graefe's Arch Klin Exp Ophthalmol, 1975, 195(4): 241-250. DOI: 10.1007/BF00414937.
|
6. |
Sigler EJ, Randolph JC, Calzada JI, et al. Current management of Coats disease[J]. Surv Ophthalmol, 2014, 59(1): 30-46. DOI: 10.1016/j.survophthal.2013.03.007.
|
7. |
Shields JA, Shields CL, Honavar SG, et al. Classification and management of Coats disease: the 2000 Proctor Lecture[J]. Am J Ophthalmol, 2001, 131(5): 572-583. DOI: 10.1016/s0002-9394(01)00896-0.
|
8. |
Daruich AL, Moulin AP, Tran HV, et al. Subfoveal nodule in Coat' disease: toward an updated classification predicting visual prognosis[J]. Retina, 2017, 37(8): 1591-1598. DOI: 10.1097/IAE.0000000000001399.
|
9. |
Ong SS, Mruthyunjaya P, Stinnett S, et al. Macular features on spectral-domain optical coherence tomography imaging associated with visual acuity in Coats' disease[J]. Invest Ophthalmol Vis Sci, 2018, 59(7): 3161-3174. DOI: 10.1167/iovs.18-24109.
|
10. |
Rabiolo A, Marchese A, Sacconi R, et al. Refining Coats' disease by ultra-widefield imaging and optical coherence tomography angiography[J]. Graefe's Arch Clin Exp Ophthalmol, 2017, 255(10): 1881-1890. DOI: 10.1007/s00417-017-3794-7.
|
11. |
Smithen LM, Brown GC, Brucker AJ, et al. Coats' disease diagnosed in adulthood[J]. Ophthalmology, 2005, 112(6): 1072-1078. DOI: 10.1016/j.ophtha.2004.12.038.
|
12. |
Zhang J, Ruan L, Jiang C, et al. Updating understanding of macular microvascular abnormalities and their correlations with the characteristics and progression of macular edema or exudation in Coats' disease[J/OL]. Front Med (Lausanne), 2022, 9: 788001[2022-04-13]. https://pubmed.ncbi.nlm.nih.gov/35492340/. DOI: 10.3389/fmed.2022.788001.
|
13. |
Vezzola D, Mapelli C, Canton V, et al. Macular fibrosis in Coats disease[J]. Retina, 2011, 31(10): 2136-2137. DOI: 10.1097/IAE.0B013E318236E861.
|
14. |
Sigler EJ, Calzada JI. Retinal angiomatous proliferation with chorioretinal anastomosis in childhood Coats disease: a reappraisal of macular fibrosis using multimodal imaging[J]. Retina., 2015, 35(3): 537-546. DOI: 10.1097/IAE.0000000000000341.
|
15. |
Ong SS, Cummings TJ, Vajzovic L, et al. Comparison of optical coherence tomography with fundus photographs, fluorescein angiography, and histopathologic analysis in assessing Coats disease[J]. JAMA Ophthalmol, 2019, 137(2): 176-183. DOI: 10.1001/jamaophthalmol.2018.5654.
|
16. |
Tan AC, Dansingani KK, Yannuzzi LA, et al. Type 3 neovascularization imaged with cross-sectional and en face optical coherence tomography angiography[J]. Retina, 2017, 37(2): 234-246. DOI: 10.1097/IAE.0000000000001343.
|